Jesse Jansen

Sep 14, 2023 | paperity.org | Brooke Nickel |Kirsten J McCaffery |Jesse Jansen |Alexandra Barratt

PLOS ONE, Jul 2023 Management of low-risk ductal carcinoma in situ (DCIS) is controversial, with clinical trials currently assessing the safety of active monitoring amidst concern about overtreatment. Little is known about general community views regarding DCIS and its management. We aimed to explore women’s understanding and views about low-risk DCIS and current and potential future management options.

Jul 21, 2023 | journals.plos.org | Brooke Nickel |Kirsten J McCaffery |Jesse Jansen |Alexandra Barratt

Loading metrics Open Access Peer-reviewedResearch Article AbstractManagement of low-risk ductal carcinoma in situ (DCIS) is controversial, with clinical trials currently assessing the safety of active monitoring amidst concern about overtreatment. Little is known about general community views regarding DCIS and its management. We aimed to explore women’s understanding and views about low-risk DCIS and current and potential future management options.